At a biohacking conference this week, a biotech CEO dropped his pants and injected himself in the thigh with an experimental herpes treatment created by his company, leaving other biohackers worried.
Former drug industry executive, Alex Azar was confirmed by a Senate vote on Wednesday as the next secretary of the Department of Health and Human Services.
To help you plan your visit, or perhaps inspire you to sign up for your free place, we’ve put together a handy guide to this year’s theme, and some of our top picks from the agenda.
Southern Illinois University’s medical school has halted all herpes research, one of its most high-profile projects, amid growing controversy over a researcher’s unauthorized methods offshore and in the U.S.
This year we can expect to see large numbers of CRISPR gene-editing trials, but some are still afraid of this amazing technology.
Sinogene, a biotech company based in Beijing has cloned a gene-edited dog in an attempt to treat cardiovascular disease.
Recent revelations that a U.S. researcher injected Americans with his experimental herpes vaccine without routine safety oversight raised an uproar among scientists and ethicists.
The NIH lifted a 3-year funding moratorium on “gain-of-function” research meant to make deadly viruses stronger and more transmissible.
Project on Government Oversight says Amicus Therapeutics CEO John Crowley sent Gottlieb a friendly note just months before their drug was FDA fast-tracked.
A team of scientists are attempting to use CRISPR to copy unique mutations from affected children into pigs, who are suffering from a genetic disorder.
The Human Rights Watch has questionned the motives behind Chinese authorities collecting DNA samples from the Xinjiang region.
The largest organisation of scientists who work in gene and cell therapy have come out against DIY gene therapies.